≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Pneumocystosis

EFO Endpoint Browser PheWeb

AB1_PNEUMOCYSTOSIS

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — B59
  • Hospital discharge: ICD-9 — 1363
  • Hospital discharge: ICD-8 — 13601
  • Cause of death: ICD-10 — B59
  • Cause of death: ICD-9 — 1363
  • Cause of death: ICD-8 — 13601

2 out of 7 registries used, show all original rules.

701

4. Check minimum number of events

None

701

5. Include endpoints

None

701

6. Filter based on genotype QC (FinnGen only)

677

Control definitions (FinnGen only)

Control exclude
AB1_PROTOZOAL

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF5

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2264 930 1311
Only index persons 1857 788 1069
Unadjusted period prevalence (%)
Whole population 0.03 0.03 0.04
Only index persons 0.04 0.03 0.04
Median age at first event (years)
Whole population 65.64 66.13 65.45
Only index persons 67.08 67.10 67.08

-FinnGen-

Key figures

All Female Male
Number of individuals 677 304 373
Unadjusted period prevalence (%) 0.14 0.11 0.17
Median age at first event (years) 68.91 68.36 69.36

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
701
Matched controls
7010
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
TGC00
NOMESCO Finland
Bronchial lavation
54.9
307.7
312
101
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
23.1
307.7
293
211
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
+∞
307.7
608
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
18.9
307.7
349
349
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
20.0
274.4
243
181
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
17.7
261.4
250
213
J18.9
ICD-10 Finland
Pneumonia, unspecified
11.3
218.0
511
1352
R50.9
ICD-10 Finland
Fever, unspecified
8.7
181.8
341
686
ZX108
NOMESCO Finland
Inhalation
48.4
169.2
100
24
XW000
NOMESCO Finland
Bone marrow biopsy
13.5
165.2
174
167
A49.9
ICD-10 Finland
Bacterial infection, unspecified
8.4
162.1
284
523
L03AA02
ATC
filgrastim; parenteral
16.2
155.7
143
109
WW500
NOMESCO Finland
Blood transfusion
12.5
140.8
154
155
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
17.6
134.6
116
78
GD1AD
NOMESCO Finland
Thorax CT examination
8.9
133.3
197
294
B59
ICD-10 Finland
Pneumocystosis
+∞
129.3
120
*
JN4AD
NOMESCO Finland
Body CT examination
6.7
127.4
276
616
ZX120
NOMESCO Finland
Intravenous
7.5
123.7
221
405
H02AB06
ATC
prednisolone; systemic
7.7
115.6
576
2618
GD1AA
NOMESCO Finland
Thorax X-ray examination
9.1
111.9
610
2971
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
6.5
111.5
235
504
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
14.0
110.5
108
90
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
9.1
109.9
152
207
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
22.3
100.7
76
38
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
6.9
99.3
183
341
H02AB02
ATC
dexamethasone; systemic
5.8
96.8
232
554
L04AA06
ATC
mycophenolic acid; systemic
15.6
91.8
83
60
L03AA13
ATC
pegfilgrastim; parenteral
8.7
90.2
126
172
A04AA01
ATC
ondansetron; systemic, rectal
6.3
89.8
181
366
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
9.0
89.8
122
161
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
8.7
89.8
126
173
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
18.3
89.5
74
45
M04AA01
ATC
allopurinol; systemic
5.2
88.6
241
637
D70.82
ICD-10 Finland
Drug-induced neutropenia
17.4
88.4
75
48
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.8
88.3
292
904
J01MA14
ATC
moxifloxacin; systemic
6.2
87.7
182
378
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.3
86.5
145
243
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
6.2
85.5
173
350
127
Kela drug reimbursment
Transplant complication
17.8
85.0
71
44
JN4BD
NOMESCO Finland
Extensive body CT
5.4
84.1
208
505
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
13.2
79.4
79
67
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
9.8
79.4
98
114
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
30.1
79.2
53
19
A03FA01
ATC
metoclopramide; systemic, rectal
4.3
78.4
311
1089
Z51.5
ICD-10 Finland
Palliative care
5.4
76.3
181
421
L04AX01
ATC
azathioprine; systemic
8.7
71.0
96
125
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
14.5
69.9
65
49
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
8.8
67.9
91
117
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
6.1
67.8
134
262
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
18.6
67.6
55
32
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.8
67.5
403
1827
J01MA12
ATC
levofloxacin; systemic
4.1
66.1
262
899
J01FF01
ATC
clindamycin; systemic
3.8
65.9
330
1328
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.8
63.4
174
452
D70.89
ICD-10 Finland
Neutropenic splenomegaly
18.9
63.3
51
29
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
25.2
63.3
45
19
C03CA01
ATC
furosemide; systemic
3.6
60.8
368
1653
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.5
60.3
183
513
TPX10
NOMESCO Finland
Implantation of vascular injection port
8.6
57.6
78
101
TK800
NOMESCO Finland
Hemodialysis
10.6
57.1
65
67
A04AA02
ATC
granisetron; systemic, transdermal
5.3
56.5
131
294
L04AD01
ATC
ciclosporin; systemic
12.6
56.5
57
49
JN6AD
NOMESCO Finland
CT of torso and neck
10.7
55.9
63
64
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.9
53.5
198
637
J05AB11
ATC
valaciclovir; oral
3.9
53.1
201
656
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
21.1
52.4
40
20
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
15.3
51.5
46
32
WW200
NOMESCO Finland
Immunization
9.3
50.2
63
74
WZC00
NOMESCO Finland
Treatment plan or consultation
3.2
49.0
385
1953
TPH04
NOMESCO Finland
Cathetrisation of vein
3.2
46.6
271
1149
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
9.0
44.8
57
68
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
13.9
44.6
42
32
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.5
44.0
66
96
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
9.6
43.9
53
59
L03AA14
ATC
lipegfilgrastim; parenteral
9.6
43.9
53
59
L04AA01
ATC
[U] ciclosporin
15.2
43.7
39
27
A02BC02
ATC
pantoprazole; systemic
4.1
42.6
600
4127
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
9.1
41.3
52
61
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
11.7
41.0
43
39
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.9
41.0
100
232
ZX112
NOMESCO Finland
Subcutaneous
7.5
40.4
60
86
N02AA05
ATC
oxycodone; systemic
3.1
40.1
235
987
L04AX03
ATC
methotrexate; systemic
4.0
40.1
133
390
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.8
40.0
98
228
R06.0
ICD-10 Finland
Dyspnoea
2.9
39.9
304
1474
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.1
39.7
231
966
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
8.8
39.4
51
62
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
8.6
39.3
52
65
A41.9
ICD-10 Finland
Sepsis, unspecified
6.0
38.8
73
134
Z94.0
ICD-10 Finland
Kidney transplant status
14.0
38.5
36
27
WX892
NOMESCO Finland
Monitored bed care
4.2
38.4
117
322
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
11.7
38.3
40
36
A07EC01
ATC
sulfasalazine; oral, rectal
4.3
36.3
105
278
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
4.8
36.0
88
204
Z49.1
ICD-10 Finland
Extracorporeal dialysis
10.8
35.4
39
38
B03XA01
ATC
erythropoietin; parenteral
13.8
35.0
33
25
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.6
34.5
89
215
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
7.3
34.4
52
76
A07AA09
ATC
vancomycin; oral
11.1
34.2
37
35
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
13.9
34.2
32
24
L01BA01
ATC
methotrexate; systemic
6.3
34.1
60
103
B03XA02
ATC
darbepoetin alfa; parenteral
7.3
33.5
51
75
L04AD02
ATC
tacrolimus; systemic
12.8
33.5
33
27
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.1
33.3
74
158
H02AB09
ATC
hydrocortisone; systemic
7.6
33.0
48
67
C90.0
ICD-10 Finland
Multiple myeloma
10.5
33.0
37
37
H02AB07
ATC
prednisone; oral
3.2
32.1
154
569
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
5.9
30.9
58
106
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.5
30.8
443
2822
A11CC03
ATC
alfacalcidol; systemic
6.8
29.8
48
75
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
6.8
29.3
47
73
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.4
28.8
120
405
L04AA13
ATC
[U] leflunomide
7.2
28.7
44
65
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
27.4
28.7
39
15
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
11.6
28.6
30
27
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.9
28.5
92
262
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
28.2
284
1521
M05BX04
ATC
denosumab; parenteral
3.9
27.6
89
253
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.1
27.6
138
519
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
9.6
27.6
33
36
B01AB10
ATC
tinzaparin; parenteral
3.1
27.5
137
514
WF049
NOMESCO Finland
Radiotherapy of metastasis
4.9
27.4
64
142
JN3AD
NOMESCO Finland
Abdominal CT examination
2.9
27.3
153
613
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.8
27.2
89
256
P01BA02
ATC
hydroxychloroquine; oral
3.5
27.1
102
322
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
27.1
145
566
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
8.9
26.8
34
40
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.0
26.8
81
220
Z2446
NOMESCO Finland
Social worker
3.9
26.5
85
241
H02AB04
ATC
methylprednisolone; systemic
2.9
26.2
152
619
1CX01, ,
NOMESCO Finland
62.6
26.2
30
5
J05AB01
ATC
aciclovir; systemic
2.5
26.0
208
996
WW300
NOMESCO Finland
Transfer of autologic stem cells
29.7
25.6
34
12
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.8
25.5
84
242
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
10.8
25.5
28
27
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
5.3
25.1
52
104
A12AA04
ATC
calcium carbonate; oral
7.2
24.4
37
54
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
9.2
24.3
30
34
D64.9
ICD-10 Finland
Anaemia, unspecified
2.9
24.1
128
496
1XC02, ,
NOMESCO Finland
22.3
23.6
34
16
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
5.5
23.3
46
88
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
23.1
351
2190
PJA10
NOMESCO Finland
Exploration of lymph nodes
7.9
23.1
32
42
B48.5
ICD-10 Finland
Pneumocystosis
+∞
23.0
22
*
J17.3
ICD-10 Finland
Pneumonia in parasitic diseases
+∞
23.0
22
*
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
6.2
22.4
39
66
L04AB04
ATC
adalimumab; parenteral
7.3
22.2
33
47
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
7.6
22.2
32
44
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.2
22.2
99
346
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.5
22.1
84
266
A05AA02
ATC
ursodeoxycholic acid; oral
8.0
21.8
30
39
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.4
21.7
186
910
R4110
NOMESCO Finland
Physiotherapy
2.2
21.6
259
1462
WX720
NOMESCO Finland
Own respiration
3.7
21.3
73
216
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.4
21.2
43
84
Z3231
NOMESCO Finland
Registered nurse
2.2
21.0
246
1371
J96.0
ICD-10 Finland
Acute respiratory failure
7.3
20.9
31
44
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.8
20.8
119
477
WF004
NOMESCO Finland
Palliative radiotherapy
5.8
20.8
39
71
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
8.5
20.6
27
33
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
43.1
20.6
25
6
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
5.1
20.4
44
91
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.9
20.3
108
417
A04AA55
ATC
palonosetron, combinations; systemic
4.3
20.0
53
130
SPAT1255
SPAT
Intravenous administration of medicine
3.4
20.0
78
251
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
4.0
19.6
57
150
XX3DW
NOMESCO Finland
Time consuming IT work
2.6
19.4
125
532
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
32.3
19.4
25
8
L04AB01
ATC
etanercept; parenteral
8.6
19.4
25
30
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.3
19.3
187
959
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.1
19.2
243
1388
C83.1
ICD-10 Finland
Mantle cell lymphoma
23.3
19.2
27
12
ZXE00
NOMESCO Finland
One hour or less
2.1
19.1
309
1935
6BA02, ,
NOMESCO Finland
56.7
19.0
22
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.0
19.0
34
59
A07AA02
ATC
nystatin; oral
3.5
19.0
70
217
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
18.9
301
1873
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.4
18.9
48
114
B01AB05
ATC
enoxaparin; parenteral
2.1
18.8
283
1722
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
71.9
18.8
21
*
R81
ICPC
Pneumonia
4.0
18.8
56
150
A03
ICPC
Fever
2.4
18.7
146
681
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.2
18.5
78
263
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
18.0
158
775
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
18.7
17.9
27
15
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
18.7
17.9
27
15
B02.9
ICD-10 Finland
Zoster without complication
3.0
17.8
84
302
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.5
17.5
63
192
J02AC03
ATC
voriconazole; systemic
24.8
17.4
24
10
A46
ICD-10 Finland
Erysipelas
2.4
17.3
146
702
212
Kela drug reimbursment
Gout
5.6
17.3
33
61
WZC30
NOMESCO Finland
Teaching
2.3
17.1
162
819
ZX120, ,
SPAT
7.4
17.0
25
35
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
5.9
16.9
31
55
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
2.3
16.9
147
716
R03AC02
ATC
salbutamol; inhalant
2.0
16.4
418
3012
J01MA02
ATC
ciprofloxacin; systemic
1.9
16.3
317
2087
390
Kela drug reimbursment
Ibrutinib
48.7
16.1
19
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
21.6
16.1
23
11
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
3.1
16.0
72
252
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.5
15.9
40
94
N18.8
ICD-10 Finland
Other chronic renal failure
4.9
15.8
35
74
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
5.3
15.7
32
63
NH3EA
NOMESCO Finland
Feet X-ray examination with load
5.7
15.4
29
53
N17.8
ICD-10 Finland
Other acute renal failure
7.2
15.3
23
33
N05CF01
ATC
zopiclone; oral
2.0
15.3
256
1593
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.4
15.2
120
559
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
15.1
220
1303
XQ855, ,
SPAT
6.7
15.0
24
37
WX882
NOMESCO Finland
High dependency care
4.2
14.9
40
99
A04AD12
ATC
aprepitant; systemic
5.0
14.9
32
66
L88
ICPC
Rheumatoid/seropositive arthritis
3.7
14.9
48
136
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.0
14.8
69
246
TDM10
NOMESCO Finland
Puncture of maxillary antrum
4.0
14.8
43
113
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
13.6
14.8
25
19
329
Kela drug reimbursment
Lenalidomide
18.9
14.8
22
12
L01AA02
ATC
chlorambucil; oral
25.7
14.7
20
8
Z3226
NOMESCO Finland
Physiotherapist
2.1
14.7
160
851
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
12.2
14.7
26
22
A10AC01
ATC
insulin (human); parenteral
2.8
14.5
77
295
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.4
14.5
37
88
WX726
NOMESCO Finland
High-flow oxygen therapy
36.9
14.5
18
5
153
Kela drug reimbursment
Lenalidomid
12.9
14.5
25
20
M05BA04
ATC
alendronic acid; oral
2.7
14.4
86
350
R05
ICD-10 Finland
Cough
2.0
14.2
182
1026
I50.9
ICD-10 Finland
Heart failure, unspecified
2.2
14.2
133
665
1512
Kela drug reimbursment
Ibrutinib
43.4
14.2
17
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.5
14.1
96
417
J01DB01
ATC
cefalexin; oral
2.3
14.0
597
5006
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.6
14.0
47
137
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
24.4
13.8
19
8
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
13.9
13.8
23
17
A06AH03
ATC
naloxegol; oral
5.9
13.8
25
44
B99
ICD-10 Finland
Other and unspecified infectious diseases
5.3
13.7
28
55
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.9
13.7
220
1340
J01CA04
ATC
amoxicillin; systemic
2.2
13.7
581
4834
L04AX04
ATC
lenalidomide; oral
12.4
13.7
24
20
JN4CD
NOMESCO Finland
Very extensive body CT
3.6
13.7
47
139
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.6
13.5
46
135
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
16.6
13.5
21
13
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.1
13.5
59
203
B34.9
ICD-10 Finland
Viral infection, unspecified
4.6
13.4
32
72
L01AA01
ATC
cyclophosphamide; systemic
18.7
13.4
20
11
XG410
NOMESCO Finland
Flow-volume spirometry
3.3
13.4
51
161
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.4
13.4
50
156
WW409
NOMESCO Finland
Other aferesis
21.7
13.4
19
9
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
13.4
141
738
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.0
13.3
39
103
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
10.0
13.3
26
27
R11
ICD-10 Finland
Nausea and vomiting
2.6
13.2
81
334
C82.1
ICD-10 Finland
Follicular lymphoma grade II
12.5
13.2
23
19
AA1AD
NOMESCO Finland
CT of head and brain
1.9
13.2
256
1656
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
13.1
321
2227
WX725
NOMESCO Finland
Noninvasive ventilation
2.9
13.1
64
234
N18.0
ICD-10 Finland
End-stage renal disease
10.3
13.1
25
25
E87.5
ICD-10 Finland
Hyperkalaemia
5.0
12.9
28
58
N02AA01
ATC
morphine; systemic, rectal
4.7
12.9
30
66
WX002
NOMESCO Finland
Sedation and analgesia
2.0
12.9
170
965
ZXD05
NOMESCO Finland
Urgent procedure
1.9
12.9
227
1422
RD210, ,
NOMESCO Finland
5.6
12.7
24
44
YNB10
NOMESCO Finland
Collection of stem cells for transplant
71.2
12.6
14
*
N02AX02
ATC
tramadol; systemic, rectal
1.8
12.6
341
2429
J17.1*B25.0
ICD-10 Finland
Cytomegaloviral pneumonitis
+∞
12.5
12
*
R06AE07
ATC
cetirizine; oral
1.8
12.3
302
2087
Z2221
NOMESCO Finland
Medical doctor
1.9
12.1
205
1263
399
Kela drug reimbursment
Venetoclax
18.4
12.1
18
10
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
8.9
12.1
25
29
A10AB05
ATC
insulin aspart; parenteral
2.6
12.0
76
318
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.2
12.0
49
162
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
15.0
11.8
19
13
L01CA04
ATC
vinorelbine; systemic
9.2
11.8
24
27
M01CB01
ATC
sodium aurothiomalate; parenteral
9.2
11.8
24
27
C07AB07
ATC
bisoprolol; oral
1.8
11.8
394
2962
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.1
11.8
50
169
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.0
11.8
25
51
3AC01, ,
NOMESCO Finland
12.8
11.7
20
16
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
30.6
11.7
15
5
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
30.6
11.7
15
5
L01EL01
ATC
ibrutinib; oral
66.1
11.6
13
*
L01XE27
ATC
[U] ibrutinib
66.1
11.6
13
*
WX110
NOMESCO Finland
Infiltration anesthesia
1.8
11.5
511
4157
B20.6
ICD-10 Finland
HIV disease resulting in Pneumocystis jirovecii pneumonia
+∞
11.5
11
*
130
Kela drug reimbursment
Malignant tumour
2.3
11.4
93
437
1518, ,
Kela drug reimbursment
17.4
11.2
17
10
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
17.4
11.2
17
10
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
25.5
11.2
15
6
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
9.4
11.1
22
24
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
10.3
11.1
21
21
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
14.2
11.0
18
13
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
10.9
180
1096
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.4
10.9
79
353
R4190
NOMESCO Finland
Nutritional therapy
3.1
10.8
45
150
C83.00
ICD-10 Finland
Lymphocytic lymphoma
28.5
10.8
14
5
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
3.2
10.7
42
135
D69.5
ICD-10 Finland
Secondary thrombocytopenia
21.9
10.7
15
7
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
60.9
10.6
12
*
J12.8
ICD-10 Finland
Other viral pneumonia
9.4
10.6
21
23
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
4.7
10.5
24
52
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.5
10.5
66
275
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
14.5
10.5
17
12
J04BA02
ATC
dapsone; oral
16.3
10.4
16
10
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
4.8
10.3
23
49
L01XX52
ATC
venetoclax; oral
19.1
10.3
15
8
V03AE01
ATC
polystyrene sulfonate; oral
5.4
10.2
20
38
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.1
10.1
42
140
ZXA00
NOMESCO Finland
Right side
1.8
10.1
212
1383
N03AX16
ATC
[U] pregabalin
1.8
10.1
182
1135
R28
ICPC
Limited function/disability (R)
5.1
10.1
21
42
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.2
10.1
88
425
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
3.8
10.1
31
85
J02AC01
ATC
fluconazole; systemic
1.7
10.0
240
1624
R02
ICPC
Shortness of breath/dyspnoea
2.0
10.0
122
669
TAB00
NOMESCO Finland
Lumbar puncture
3.0
10.0
46
163
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.0
10.0
44
152
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
40.7
10.0
12
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
9.9
120
656
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
9.9
167
1019
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
4.4
9.9
25
59
A02BC01
ATC
omeprazole; systemic
1.8
9.9
205
1331
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
8.3
9.9
21
26
L01BB05
ATC
fludarabine; systemic
26.4
9.8
13
5
L04AA24
ATC
abatacept; parenteral
20.4
9.8
14
7
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
4.8
9.8
22
47
XX1XW
NOMESCO Finland
Extensive written report from radiologist
4.2
9.8
26
64
WX610
NOMESCO Finland
Patient controlled analgesia
13.6
9.7
16
12
N02BE01
ATC
paracetamol; systemic, rectal
2.4
9.7
643
5762
WW400
NOMESCO Finland
Plasmaferesis
55.8
9.7
11
*
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.0
9.7
44
155
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.7
9.6
54
213
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
5.1
9.6
20
40
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
8.5
9.6
20
24
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.0
9.6
43
150
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
4.9
9.6
21
44
M31.3
ICD-10 Finland
Wegener granulomatosis
15.3
9.5
15
10
SPAT1262
SPAT
Handing over of treatment supplies
1.9
9.5
148
881
Z94.2
ICD-10 Finland
Lung transplant status
30.5
9.4
12
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.4
9.4
69
309
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
7.1
9.4
22
32
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
7.1
9.4
22
32
J01AA02
ATC
doxycycline; systemic
1.8
9.4
547
4652
C08CA01
ATC
amlodipine; oral
1.6
9.3
311
2287
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
9.3
127
723
N19
ICD-10 Finland
Unspecified kidney failure
2.9
9.3
43
153
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
9.2
272
1937
A02BC05
ATC
esomeprazole; systemic
1.6
9.2
295
2145
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.0
9.2
26
67
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
13.9
9.2
15
11
UJF32
NOMESCO Finland
Coloscopy
1.7
9.1
207
1374
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.1
9.1
87
435
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
9.2
9.1
18
20
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
37.2
9.0
11
*
J96.1
ICD-10 Finland
Chronic respiratory failure
3.6
9.0
29
82
A41.8
ICD-10 Finland
Other specified sepsis
3.9
9.0
26
68
EBA10
NOMESCO Finland
Operative extraction of tooth
2.2
9.0
84
417
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
24.4
8.9
12
5
XF600
NOMESCO Finland
Bloodpressure measurement
2.5
8.9
58
246
137
Kela drug reimbursment
Uraemia requiring dialysis
8.1
8.9
19
24
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
8.1
8.9
19
24
Z3229
NOMESCO Finland
Other healthcare associate professional
2.3
8.9
70
324
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.4
8.9
64
285
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
8.8
273
1965
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.7
8.8
48
187
J47
ICD-10 Finland
Bronchiectasis
3.7
8.8
28
79
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
6.7
8.7
21
32
120
Kela drug reimbursment
Hypogammaglobulinaemia
50.6
8.7
10
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
4.0
8.7
24
61
V03AE02
ATC
sevelamer; oral
11.8
8.6
15
13
TQW99
NOMESCO Finland
Other minor procedure on skin
2.6
8.6
52
213
ZXA05
NOMESCO Finland
Left side
1.7
8.6
188
1233
WX402
NOMESCO Finland
General anaesthesia
1.7
8.6
173
1109
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
3.4
8.6
30
90
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
27.9
8.5
11
*
SPAT1325
SPAT
Vaccination
1.6
8.5
255
1817
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
8.5
151
934
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
6.8
8.4
20
30
HA1AA
NOMESCO Finland
X-ray mammography
2.3
8.3
66
306
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
9.6
8.3
16
17
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.5
8.3
28
82
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.5
8.3
63
1244
ZX121
NOMESCO Finland
Central venous catheter
14.7
8.2
13
9
R03BB04
ATC
tiotropium bromide; inhalant
2.0
8.2
89
467
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.7
8.2
44
170
E0000UV, ,
ATC
1.6
8.2
290
2146
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
3.3
8.2
30
93
A06AD11
ATC
lactulose; oral
1.9
8.1
118
684
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
8.1
319
2417
RS220, ,
NOMESCO Finland
6.9
8.1
19
28
B01AB04
ATC
dalteparin; parenteral
2.7
8.1
43
165
GDG10
NOMESCO Finland
Bilateral transplantation of lung
33.8
8.1
10
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.0
8.1
35
120
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.7
8.1
25
69
WPB10
NOMESCO Finland
Making a convalescent care decision
9.1
8.1
16
18
GX1K5
NOMESCO Finland
Diffusion capacity
9.1
8.1
16
18
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.1
8.1
78
392
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.8
8.1
40
148
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
4.0
7.9
22
56
K65.0
ICD-10 Finland
Acute peritonitis
6.7
7.9
19
29
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
6.7
7.9
19
29
L04AX05
ATC
pirfenidone; oral
13.2
7.9
13
10
V03AE03
ATC
lanthanum carbonate; oral
13.2
7.9
13
10
RS221, ,
NOMESCO Finland
6.2
7.9
20
33
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
6.2
7.9
20
33
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
6.2
7.9
20
33
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.6
7.9
26
75
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.3
7.9
59
267
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
8.6
7.8
16
19
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
6.0
7.7
20
34
B74
ICPC
Malignant neoplasm blood other
45.5
7.7
9
*
B73
ICPC
Leukaemia
45.5
7.7
9
*
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
45.5
7.7
9
*
R03BA08
ATC
ciclesonide; inhalant
2.2
7.6
67
324
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
6.8
7.6
18
27
A08.1
ICD-10 Finland
Acute gastroenteropathy due to Norovirus
18.6
7.6
11
6
TPX15
NOMESCO Finland
Removal of vascular injection port
12.0
7.6
13
11
R04.2
ICD-10 Finland
Haemoptysis
2.9
7.5
35
125
Z49.0
ICD-10 Finland
Preparatory care for dialysis
7.2
7.5
17
24
R03AK08
ATC
formoterol and beclometasone; inhalant
2.7
7.5
39
148
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
4.5
7.5
18
41
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
7.5
146
925
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.5
7.5
25
73
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.5
7.4
48
203
GD2SN
NOMESCO Finland
Lung ventilation SPECT
7.8
7.4
16
21
R2110
NOMESCO Finland
Giving the first information
2.5
7.4
46
191
NG1DA
NOMESCO Finland
X-ray of knees
3.8
7.4
22
59
FM1FN
NOMESCO Finland
Heart function isotope examination
13.5
7.4
12
9
L01BC06
ATC
capecitabine; oral
2.6
7.4
41
161
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
4.1
7.4
20
50
ED1AA
NOMESCO Finland
Mandibular X-ray examination
8.5
7.3
15
18
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.5
7.3
44
180
B05DB
ATC
Hypertonic solutions
9.5
7.3
14
15
J15.8
ICD-10 Finland
Other bacterial pneumonia
9.5
7.3
14
15
284
Kela drug reimbursment
Nintedanib and pirfenidone
9.5
7.3
14
15
1363A
ICD-9 Finland
Other and unspecified infectious and parasitic diseases, Pneumocystosis
+∞
7.3
7
*
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.3
7.3
57
263
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
6.3
7.3
18
29
WX722
NOMESCO Finland
PEEP
2.5
7.3
46
193
WVA20
NOMESCO Finland
Medicine administration
3.0
7.3
32
111
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.8
7.2
22
60
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
7.2
143
910
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.4
7.2
25
75
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
30.3
7.2
9
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
30.3
7.2
9
*
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
20.3
7.1
10
5
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.7
7.1
39
152
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.7
7.1
39
152
N03AX14
ATC
levetiracetam; systemic
3.1
7.1
29
96
WF002
NOMESCO Finland
Radical radiotherapy
2.2
7.1
59
279
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
12.2
7.1
12
10
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
8.9
7.1
14
16
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.8
7.0
35
130
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.6
7.0
40
160
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
13.9
6.9
11
8
ZX080
NOMESCO Finland
Image guided radiotherapy
3.3
6.9
25
77
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
8.4
6.8
14
17
TGD00
NOMESCO Finland
Needle biopsy of lung
8.4
6.8
14
17
1CD02, ,
NOMESCO Finland
6.8
6.8
16
24
356
Kela drug reimbursment
Nintedanib and pirfenidone
9.4
6.8
13
14
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
6.2
6.8
17
28
J16.8
ICD-10 Finland
Pneumonia due to other specified infectious organisms
40.5
6.8
8
*
L01BB01, ,
ATC
40.5
6.8
8
*
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
40.5
6.8
8
*
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.9
6.8
31
110
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.5
6.7
23
68
J01FA06
ATC
roxithromycin; oral
1.5
6.7
269
2023
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
6.0
6.6
17
29
Z49.2
ICD-10 Finland
Other dialysis
7.9
6.6
14
18
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.2
6.6
56
267
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
3.4
6.6
23
69
P01AB01
ATC
metronidazole; oral, rectal
1.5
6.6
263
1976
H05BX01
ATC
cinacalcet; oral
8.8
6.6
13
15
JAH01
NOMESCO Finland
Laparoscopy
2.7
6.6
35
135
D07AC01
ATC
betamethasone; topical
1.5
6.6
253
1886
H05AA02
ATC
teriparatide; parenteral
10.2
6.6
12
12
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
10.2
6.6
12
12
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.6
6.5
36
141
A28
ICPC
Limited function/disability NOS
1.7
6.5
142
923
Z51.88
ICD-10 Finland
Other specified medical care
3.7
6.5
20
55
DHA10
NOMESCO Finland
Biopsy of cavity of nose
6.3
6.5
16
26
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
3.6
6.5
21
60
ZX100
NOMESCO Finland
Oral
4.0
6.5
18
46
M31.1
ICD-10 Finland
Thrombotic microangiopathy
70.5
6.4
7
*
1AA09, ,
NOMESCO Finland
70.5
6.4
7
*
L04AA10
ATC
[U] sirolimus
70.5
6.4
7
*
WW402
NOMESCO Finland
Leucoferesis
70.5
6.4
7
*
ZX131
NOMESCO Finland
Intrathecal
70.5
6.4
7
*
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
7.5
6.4
14
19
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
14.5
6.4
10
7
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
14.5
6.4
10
7
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
14.5
6.4
10
7
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.6
6.4
185
1292
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
8.3
6.4
13
16
J46
ICD-10 Finland
Status asthmaticus
3.4
6.3
22
66
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
11.2
6.3
11
10
318
Kela drug reimbursment
Teriparatide
9.4
6.3
12
13
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
9.4
6.3
12
13
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
+∞
6.3
6
*
KAS40
NOMESCO Finland
Excision of transplanted kidney
+∞
6.3
6
*
1XX08, ,
NOMESCO Finland
+∞
6.3
6
*
SPAT1263
SPAT
Sampling
1.5
6.2
283
2177
H26.3
ICD-10 Finland
Drug-induced cataract
7.1
6.2
14
20
B05DA
ATC
Isotonic solutions
7.1
6.2
14
20
293
Kela drug reimbursment
Baricitinib
26.9
6.2
8
*
L04AA37
ATC
[U] baricitinib
26.9
6.2
8
*
3006
Kela drug reimbursment
Baricitinib
26.9
6.2
8
*
XX2RW, ,
NOMESCO Finland
5.1
6.2
18
36
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.3
6.2
23
72
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
6.4
6.2
15
24
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
7.8
6.1
13
17
ZXA10
NOMESCO Finland
Bilateral
1.7
6.1
133
864
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
12.7
6.1
10
8
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
8.7
6.1
12
14
TK820
NOMESCO Finland
Peritoneal dialysis
8.7
6.1
12
14
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
6.8
6.1
14
21
196
Kela drug reimbursment
Paricalcitol and cinacalcet
10.1
6.0
11
11
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
5.6
6.0
16
29

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 500 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Proper column names.
  • Show details (e.g. Fisher or Chi-square test, N cases and N controls) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV not working.
  • No filters and sorters.
  • Limited amount of endpoints with TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP Concept
ln(OR) -5y
ln(OR) -1y
ln(OR) -1m
ln(OR) d0
ln(OR) +1m
ln(OR) +1y
ln(OR) +5y
MCC -5y
MCC -1y
MCC -1m
MCC d0
MCC +1m
MCC +1y
MCC +5y
Other bronchoscopic procedure on bronchus
GCA98 (2001303606)
Pneumonia due to Pneumocystis carinii
J17.3*B59 (2000502585)
Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5000-5 (3020229)
Pneumocystosis
B59 (45566559)
Paranasal sinuses X-ray examination in one projection
DM1QA (2001301761)
Bronchial lavation
TGC00 (2001303585)
SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: Unspecified
SMOKING-2-3-0 (2002330113)
diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus
J07CA06 (21601377)
Streptococcus pneumoniae Ag [Presence] in Urine
24027-5 (3011363)
Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7993-9 (3025023)
Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
34720-3 (3030558)
Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
49672-9 (3032699)
Legionella sp identified in Specimen by Organism specific culture
593-4 (3037692)
Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
29723-4 (3037875)
Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
41009-2 (3038546)
Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
41005-0 (3040359)
Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
41003-5 (3041642)
Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
61366-1 (40764127)
Body height measure
50373000 (4177340)
Body mass index
60621009 (4245997)
Paranasal sinuses X-ray examination without contrast
DM1AA (2001301740)
Thorax extensive CT-examination
GD1BD (2001303621)
Extensive high resolution CT examination of lungs
GD1ED (2001303637)
PEEP
WX722 (2001310825)
Intensive care
WX872 (2001310844)
SMOKING - SMOKE2: no - SMOKE3: former - SMOKE5: Unspecified
SMOKING-2-2-0 (2002330110)
Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
82134-8 (21493195)
Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
30076-4 (3000108)
Band form neutrophils/Leukocytes in Blood
26508-2 (3004809)
Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
30075-6 (3005156)
CD3-CD19+ cells/cells in Blood
15196-9 (3006245)
Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
29910-7 (3006262)
CD3+CD8+ (T8 suppressor) cells/cells in Blood
8101-8 (3007449)
Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
29909-9 (3012158)
Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
23826-1 (3012477)
Potassium [Moles/volume] in Urine
2828-2 (3016038)
Enterovirus RNA [Presence] in Specimen by NAA with probe detection
29591-5 (3016881)
Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21363-7 (3020565)
Bacteria identified in Sputum by Culture
6460-0 (3023419)
Influenza virus A+B Ag [Presence] in Specimen
24015-0 (3024891)
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
9728-7 (3025271)
Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
29908-1 (3025634)
Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
20444-6 (3028369)
Actinomyces sp identified in Specimen by Organism specific culture
9816-0 (3028371)
Virus identified in Specimen by Culture
6584-7 (3028433)
Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
50548-7 (3030692)
Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34645-2 (3031478)
Mycobacterium tuberculosis genotype [Identifier] in Isolate
35352-4 (3036432)
Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
41010-0 (3038297)
Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
41001-9 (3042596)
Mycobacterium sp identified in Specimen
40699-1 (3042631)
Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
46083-2 (3043362)
Bone marrow Pathology biopsy report
33721-2 (3045142)
Anion gap in Serum or Plasma by calculation
33037-3 (3045716)
Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
46082-4 (3046524)
Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
61365-3 (40764126)
Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 (40765161)
Mantle cell lymphoma
C83.1 (45542646)
Acute drug-induced interstitial lung disorders
J70.2 (45548121)
Other transplanted organ and tissue status
Z94.8 (45600381)
CD3 cells/Lymphocytes in Blood
90304-7 (1175426)
Gas panel - Central venous blood
97535-9 (1616796)
Drug-induced neutropenia
D70.82 (2000501376)
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA (2001301913)
CT examination of arteria pulmonalis
FB1AD (2001302404)
Extensive CT examination of arteria pulmonalis
FB1BD (2001302407)
ECG with 12 standard connections
XF400 (2001303368)
Flexible bronchoscopy
UGC12 (2001303610)
High resolution CT examination of lungs
GD1DD (2001303632)
X-ray examination of the lungs in one projection
GD1PA (2001303645)
Supine thorax X-ray examination
GD1QA (2001303648)
Abdominal ultrasound examination
JN3AE (2001305555)
Joint ultrasound examination not elsewhere classified
NK4XE (2001308469)
Ultrasound examination of lower leg veins
PH2AE (2001309451)
Cathetrisation of vein
TPH04 (2001309597)
Insertion of central venous catheter through external or internal jugular vein
TPH15 (2001309600)
Insertion of central venous catheter through subclavian or brachiocephalic vein
TPH20 (2001309601)
Cathetrisation of artery
TPH07 (2001309747)
Blood transfusion
WW500 (2001310603)
Bone marrow biopsy
XW000 (2001310618)
Simple antiboidy therapy of methastized malignancy
WD405 (2001310688)
Palliative radiotherapy
WF004 (2001310703)
Respiratory and circulatory monitoring
WX700 (2001310817)
Monitored bed care
WX892 (2001310850)
Extensive body CT
JN4BD (2001310899)
CT of torso and neck
JN6AD (2001310938)
Urgent procedure
ZXD05 (2001311386)
One hour or less
ZXE00 (2001311394)
Other technic of radiotherapy
ZX090 (2001311480)
Intravenous
ZX120 (2001311495)
Medical doctor
Z2221 (2001311556)
Social worker
Z2446 (2001311559)
Physiotherapist
Z3226 (2001311560)
Breast cancer
115 (2001600115)
Fever
A03 (2002000144)
Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
80721-4 (21493690)
CD8 cells/Lymphocytes in Specimen
80222-3 (21494814)
aprepitant; oral, parenteral
A04AD12 (21600505)
calcium (different salts in combination); oral
A12AA20 (21600872)
methotrexate
L01BA01 (21601423)
furosemide; oral, parenteral
C03CA01 (21601518)
amlodipine; oral
C08CA01 (21601747)
methotrexate; oral, parenteral
L04AX03 (21603929)
zopiclone; oral
N05CF01 (21604654)
Fungus identified in Specimen by Culture
580-1 (3000494)
Epithelial cells [#/volume] in Urine
30383-4 (3000850)
Blood group antibody screen [Presence] in Serum or Plasma
890-4 (3001079)
CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
14135-8 (3001405)
Herpes simplex virus Ag [Presence] in Specimen
16945-8 (3001964)
Base excess in Venous blood by calculation
1927-3 (3002032)
Metamyelocytes/Leukocytes in Blood
28541-1 (3002179)
Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29257-3 (3002482)
Sodium [Moles/volume] in Urine
2955-3 (3003181)
Hemoglobin [Mass/volume] in Venous blood
30350-3 (3004119)
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 (3004529)
Mycobacterium sp identified in Specimen by Organism specific culture
543-9 (3005702)
IgG [Mass/volume] in Serum or Plasma
2465-3 (3005719)
Hemoglobin [Mass/volume] in Capillary blood
30352-9 (3006184)
Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
29904-0 (3006695)
Lactate [Moles/volume] in Venous blood
2519-7 (3008037)
Aspergillus sp Ab [Presence] in Serum
7808-9 (3008536)
Leukocyte morphology finding [Identifier] in Blood
11156-7 (3008757)
Proteinase 3 Ab [Units/volume] in Serum
6968-2 (3009445)
Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection
6521-9 (3009595)
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 (3010130)
Herpes simplex virus identified in Specimen by Organism specific culture
5859-4 (3010254)
pH of Blood
11558-4 (3010421)
CD19 cells [#/volume] in Blood
8116-6 (3010503)
Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 (3010517)
CD3 cells [#/volume] in Blood
8122-4 (3011412)
Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
11483-5 (3012202)
Base excess in Blood by calculation
11555-0 (3012501)
pH of Venous blood
2746-6 (3012544)
Carbon dioxide [Partial pressure] in Blood
11557-6 (3013290)
Protein [Presence] in Urine by Test strip
20454-5 (3014051)
Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 (3014162)
Toxoplasma gondii IgG Ab [Units/volume] in Serum
8039-0 (3014959)
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 (3015635)
CD19 cells/cells in Blood
8117-4 (3016228)
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 (3016293)
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 (3016417)
Myelocytes/Leukocytes in Blood
26498-6 (3017181)
Oxygen content in Arterial blood
19218-7 (3017569)
Neutrophils [#/volume] in Blood
26499-4 (3017732)
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 (3017918)
Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
7970-7 (3018387)
Lactate [Moles/volume] in Arterial blood
2518-9 (3018405)
aPTT in Platelet poor plasma by Coagulation assay
14979-9 (3018677)
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
20607-8 (3020073)
Body temperature
8310-5 (3020891)
Promyelocytes/Leukocytes in Blood
26524-9 (3021440)
Carbon dioxide [Partial pressure] in Venous blood
2021-4 (3021447)
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 (3022250)
Fractional oxyhemoglobin in Capillary blood
2715-1 (3022806)
Reticulocytes [#/volume] in Blood
14196-0 (3023520)
IgG subclass 3 [Mass/volume] in Serum
2468-7 (3024139)
Oxygen [Partial pressure] in Venous blood
2705-2 (3024354)
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 (3024889)
Blasts/Leukocytes in Blood
26446-5 (3025159)
Bacteria identified in Urine by Culture
630-4 (3026008)
Osmolality of Urine
2695-5 (3026782)
IgG subclass 1 [Mass/volume] in Serum
2466-1 (3027135)
Bicarbonate [Moles/volume] in Venous blood
14627-4 (3027273)
Oxygen [Partial pressure] in Blood
11556-8 (3027315)
Toxoplasma gondii IgM Ab [Units/volume] in Serum
8040-8 (3027529)
CD3-CD16+CD56+ (Natural killer) cells/cells in Blood
8112-5 (3027831)
Reticulocytes/Erythrocytes in Blood
4679-7 (3027945)
CD3+CD4+ (T4 helper) cells [#/volume] in Blood
24467-3 (3028167)
IgG subclass 2 [Mass/volume] in Serum
2467-9 (3028192)
Lactate [Moles/volume] in Capillary blood
19239-3 (3028271)
Oxygen [Partial pressure] in Capillary blood
2704-5 (3028626)
Hyaline casts [#/volume] in Urine by Automated count
51484-4 (3030981)
Glomerular basement membrane Ab [Units/volume] in Serum
49774-3 (3032700)
Granulocytes [#/volume] in Blood
30394-1 (3035715)
Granulocytes/Leukocytes in Blood
30395-8 (3035933)
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 (3038288)
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 (3040853)
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 (3042194)
Bacteria identified in Isolate by Culture
43409-2 (3042936)
Potassium [Moles/volume] in Arterial blood
32713-0 (3043409)
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 (3043849)
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 (3043924)
Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40988-8 (3044254)
Blood type and Crossmatch panel - Blood
34531-4 (3044640)
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 (3044938)
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 (3045783)
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 (3046279)
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 (3051552)
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 (3051714)
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 (36031861)
Microscopic observation [Identifier] in Isolate by Gram stain
87975-9 (36305247)
General Practice Dentistry
1223G0001X (38003675)
Infectious Disease
44 (38004484)
Immunoglobulin typing, IgG
1712009 (4062490)
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
54218-3 (40757349)
Microorganisms panel - Urine sediment
58435-9 (40761536)
Oxygen content in Capillary blood by calculation
64799-0 (40767503)
Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
66885-5 (40769539)
Myosin Ab [Presence] in Serum or Plasma by Immunoblot
72458-3 (43055089)
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 (43055120)
Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
71668-8 (43055361)
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 (43055554)
Parainfluenza type 1 nucleic acid detection
222341000000100 (44790047)
Parainfluenza type 2 nucleic acid detection
222351000000102 (44790048)
Parainfluenza type 3 nucleic acid detection
222361000000104 (44790049)
Parainfluenza type 4 nucleic acid detection
810871000000102 (44806118)
Follicular lymphoma grade II
C82.1 (45532946)
Non-follicular (diffuse) lymphoma, unspecified
C83.9 (45542649)
Interstitial pulmonary disease, unspecified
J84.9 (45543277)
Palliative care
Z51.5 (45547323)
Other specified interstitial pulmonary diseases
J84.8 (45548126)
Abnormal findings on diagnostic imaging of lung
R91 (45548995)
Pulmonary embolism without mention of acute cor pulmonale
I26.9 (45552785)
Bacterial pneumonia, unspecified
J15.9 (45557621)
Other interstitial pulmonary diseases with fibrosis
J84.1 (45557630)
Chronic respiratory failure
J96.1 (45557632)
Dyspnoea
R06.0 (45558449)
Acute bronchitis, unspecified
J20.9 (45562445)
Asthma, unspecified
J45.9 (45562456)
Kidney transplant status
Z94.0 (45566477)
Acute renal failure, unspecified
N17.9 (45567829)
Heart failure, unspecified
I50.9 (45576879)
Thrombocytopenia, unspecified
D69.6 (45581327)
Fever, unspecified
R50.9 (45582716)
Bacterial infection, unspecified
A49.9 (45590816)
Anaemia, unspecified
D64.9 (45600610)
Acute respiratory failure
J96.0 (45605905)
Emergency use of U07.1 | COVID-19, virus identified
U07.1 (45756093)
Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
76080-1 (46235759)
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 (46236098)
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 (586526)
Pneumocystosis
B48.5 (710652)
Inpatient Hospital
21 (8717)
sulfamethoxazole and trimethoprim
J01EE01 (21602961)
Neutrophils [#/volume] in Blood by Automated count
751-8 (3013650)
Diffuse lymphoma with large B cells
C83.31 (2000501224)
Monocytes/Leukocytes in Blood
26485-3 (3019069)
Lymphocytes/Leukocytes in Blood
26478-8 (3002030)
Basophils/Leukocytes in Blood
30180-4 (3022096)
Eosinophils/Leukocytes in Blood
26450-7 (3006504)
Eosinophils [#/volume] in Blood
26449-9 (3013115)
Lymphocytes [#/volume] in Blood
26474-7 (3019198)
Basophils [#/volume] in Blood
26444-0 (3006315)
Monocytes [#/volume] in Blood
26484-6 (3001604)
Neutrophils/Leukocytes in Blood
26511-6 (3018010)
Differential panel, method unspecified - Blood
69738-3 (42870588)
Medical Oncology
90 (38004507)
Demanding cystostatic therapy of methastized malignancy
WD125 (2001310680)
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 (3006140)
Emergency Room Visit
ER (9203)
Multiple myeloma
C90.0 (45600562)
Hematology
82 (38004501)
Chronic lymphocytic leukaemia of B-cell type
C91.1 (45600564)
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 (3035995)
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 (3020460)
Pneumonia, unspecified
J18.9 (45601123)
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 (3021347)
IgM [Mass/volume] in Serum or Plasma
2472-9 (3028026)
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 (3016431)
Hemodialysis
TK800 (2001305768)
Normoblasts [#/volume] in Blood
715-3 (3021589)
darbepoetin alfa; parenteral
B03XA02 (21601134)
Immunoglobulin light chains.free panel - Serum
57778-3 (40760888)
Bacteria identified in Blood by Culture
600-7 (3023368)
Thorax X-ray examination
GD1AA (2001303617)
HIV 1 and 2 tests - Meaningful Use set
75622-1 (46235355)
cycloSPORINE [Mass/volume] in Blood
3520-4 (3010375)
Bacteria [#/volume] in Urine by Automated count
51480-2 (3031040)
rituximab
L01FA01 (955167)
Magnesium [Moles/volume] in Serum or Plasma
2601-3 (3012095)
Gas panel - Arterial blood
24336-0 (3019060)
Oxygen [Partial pressure] in Arterial blood
2703-7 (3027801)
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 (3027946)
Kappa light chains.free [Mass/volume] in Serum
36916-5 (3034860)
Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 (3047169)
prednisolone
A07EA01 (21600653)
prednisolone; oral, parenteral
H02AB06 (21602734)
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 (3013707)
pH of Arterial blood
2744-1 (3019977)
Pulmonary Disease
29 (38004472)
CBC W Ordered Manual Differential panel - Blood
57782-5 (40760892)
Hepatitis B virus core Ab [Presence] in Serum
16933-4 (3021879)
Base excess in Arterial blood by calculation
1925-7 (3003396)
pegfilgrastim; parenteral
L03AA13 (21603856)
Cortisol [Moles/volume] in Serum or Plasma
14675-3 (3036481)
Hemoglobin [Mass/volume] in Arterial blood
30313-1 (3002173)
Emergency Medicine
93 (38004510)
valaciclovir; oral
J05AB11 (21603137)
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 (3002385)
ciclosporin; oral, parenteral
L04AD01 (21603924)
CD4 cells/Lymphocytes in Specimen
80223-1 (21494815)
Body CT examination
JN4AD (2001310897)
Cystostatic therapy of methastized malignancy
WD105 (2001310678)
Tacrolimus [Mass/volume] in Blood
11253-2 (3026250)
tacrolimus; oral, parenteral
L04AD02 (21603925)
Nuclear Ab [Titer] in Serum
29953-7 (3037522)
Oxygen saturation in Arterial blood
2708-6 (3016502)
prednisone
A07EA03 (21600655)
prednisone; oral
H02AB07 (21602735)
Sodium [Moles/volume] in Serum or Plasma
2951-2 (3019550)
Potassium [Moles/volume] in Serum or Plasma
2823-3 (3023103)
ondansetron; oral, parenteral, rectal
A04AA01 (21600493)
Creatinine [Moles/volume] in Serum or Plasma
14682-9 (3020564)
clindamycin; oral, parenteral
J01FF01 (21602985)
Protein [Mass/volume] in Serum or Plasma
2885-2 (3020630)
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 (3048816)
mycophenolic acid; oral, parenteral
L04AA06 (21603896)
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 (3006923)
Protein electrophoresis panel - Serum or Plasma
24351-9 (3004588)
Platelets [#/volume] in Blood
26515-7 (3007461)
MCH [Entitic mass]
28539-5 (3035941)
MCV [Entitic mean volume] in Red Blood Cells
30428-7 (3024731)
Erythrocytes [#/volume] in Blood
26453-1 (3026361)
Hemoglobin [Mass/volume] in Blood
718-7 (3000963)
Leukocytes [#/volume] in Blood
26464-8 (3010813)
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 (3009542)
IgA [Mass/volume] in Serum or Plasma
2458-8 (3007164)
Secondary malignant neoplasm of other specified sites
C79.8 (45547524)
Metastasis
OMOP4998856 (36769180)
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 (3019902)
filgrastim; parenteral
L03AA02 (21603851)
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 (3001668)
FEV1 --post bronchodilation
20155-8 (3023550)
FEV1/FVC --post bronchodilation
69970-2 (42868459)
FVC percent change Respiratory system
69982-7 (42868471)
FEV1 percent change
69983-5 (42868472)
FEV1/FVC
19926-5 (3011505)
Forced vital capacity [Volume] Respiratory system
19870-5 (3020158)
FEV1
20150-9 (3024653)
Phosphate [Moles/volume] in Serum or Plasma
14879-1 (3003458)
Other seropositive rheumatoid arthritis
M05.8 (45538634)
pH of Serum or Plasma
2753-2 (3018418)
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 (3007628)
Fractional oxyhemoglobin in Arterial blood
2714-4 (3014007)
Gas panel - Venous blood
24339-4 (3000991)
methylprednisolone; oral, parenteral
H02AB04 (21602732)
Internal Medicine
11 (38004456)
Urea [Moles/volume] in Serum or Plasma
22664-7 (3020779)
Hepatitis C virus Ab [Presence] in Serum
16128-1 (3017143)
calcium carbonate
A02AC01 (21600065)
calcium carbonate; oral
A12AA04 (21600863)
Demanding antibody therapy of methastized malignancy
WD415 (2001310689)
pH of Capillary blood
2745-8 (3009343)
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 (3023024)
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 (3019284)
azathioprine; oral, parenteral
L04AX01 (21603927)
nystatin; oral
A07AA02 (21600604)
Nephrology
39 (38004479)
dexamethasone; oral, parenteral
H02AB02 (21602730)
Office Visit
OMOP4822458 (581477)
INR in Blood by Coagulation assay
34714-6 (3032080)
Rheumatology
66 (38004491)
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 (3028653)
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 (3043747)
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 (3005229)
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 (3043723)
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 (3006217)
metoclopramide; oral, parenteral, rectal
A03FA01 (21600484)
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 (3023465)
CBC panel - Blood by Automated count
58410-2 (40761511)
Chloride [Moles/volume] in Serum or Plasma
2075-0 (3014576)
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 (3015322)
Morphology [Interpretation] in Bone marrow Narrative
51628-6 (3042111)
Emergency Room and Inpatient Visit
ERIP (262)
Bacteria identified in Skin by Aerobe culture
620-5 (3007853)
Outpatient Visit
OP (9202)
granisetron; oral, parenteral, transdermal
A04AA02 (21600494)
Short blood count panel - Blood
55429-5 (40758558)
alfacalcidol; oral, parenteral
A11CC03 (21600818)
Bacteria [Presence] in Urine
87829-8 (36304419)
ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 (2002330215)
Supplier / Service Provider
OMOP5117446 (33004)
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 (3049804)
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 (3029287)
Lactate [Moles/volume] in Serum or Plasma
2524-7 (3014111)
Albumin [Mass/volume] in Serum or Plasma
1751-7 (3024561)
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 (40764999)
Casts [#/volume] in Urine by Automated count
51483-6 (3030467)
Calcium [Moles/volume] in Serum or Plasma
2000-8 (3015377)
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 (3035797)
Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15189-4 (3007778)
Urate [Moles/volume] in Serum or Plasma
14933-6 (3026493)
Outpatient Hospital
22 (8756)
Laboratory Visit
OMOP4822461 (32036)
tinzaparin; parenteral
B01AB10 (21600981)
Transferrin [Mass/volume] in Serum or Plasma
3034-6 (3004789)
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 (40763571)
IgG subclass 4 [Mass/volume] in Serum
2469-5 (3024980)
Erythrocytes [#/volume] in Urine
30391-7 (3002582)
Myeloperoxidase Ab [Units/volume] in Serum
6969-0 (3023150)
Natriuretic peptide B [Mass/volume] in Serum or Plasma
30934-4 (3011960)
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 (3003338)
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
117 (2001600117)
Treatment plan or consultation
WZC00 (2001310885)
denosumab; parenteral
M05BX04 (21604169)
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 (3029713)
Abdominal CT examination
JN3AD (2001305554)
Mycobacterium sp identified in Sputum by Organism specific culture
539-7 (3027544)
Iron [Moles/volume] in Serum or Plasma
14798-3 (3022948)
EKG study
11524-6 (3013512)
Leukocytes [#/volume] in Urine
30405-5 (3018095)
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 (40762366)
Glucose [Moles/volume] in Serum or Plasma
14749-6 (3013826)
Inpatient Visit
IP (9201)
levofloxacin; inhalant, oral, parenteral
J01MA12 (21603019)
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 (3013742)
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 (3005772)
Pharmacy visit
OMOP4822462 (581458)
Microscopic observation [Identifier] in Buccal smear by Cyto stain
18501-7 (3018559)
Erythrocytes [Presence] in Urine by Automated
53292-9 (3041096)
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31374-2 (3007080)
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5159-9 (3007844)
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 (3023081)
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 (3021337)
Physiotherapy
R4110 (2001310233)
CD3+CD4+ (T4 helper) cells/cells in Blood
8123-2 (3014037)
Prothrombin time (PT) actual/Normal
5894-1 (3033658)
oxycodone; oral, parenteral
N02AA05 (21604260)
Methemoglobin/Hemoglobin.total in Blood
2614-6 (3007930)
Bicarbonate [Moles/volume] in Arterial blood
1960-4 (3008152)
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 (21602863)
FISTULA - Fistula
FISTULA-1 (2002330212)
Immunohistochemistry procedure
117617002 (4035726)
aciclovir; oral, parenteral
J05AB01 (21603131)
Epstein Barr virus Ab [Presence] in Serum
49178-7 (3048929)
Thorax X-ray examination outside radiological department
GD1UA (2001303652)
moxifloxacin; oral, parenteral
J01MA14 (21603021)
Essential (primary) hypertension
I10 (45591453)
Thoracic and Cardiac Surgery
OMOP4822009 (45756830)
Chronic kidney disease, unspecified
N18.9 (45553438)
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 (706163)
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 (3013721)
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 (3029879)
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 (3029187)
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 (3030306)
Rheumatoid factor [Units/volume] in Serum or Plasma
11572-5 (3021614)
enoxaparin; parenteral
B01AB05 (21600976)
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 (2001304788)
Urinalysis macro (dipstick) panel - Urine
24357-6 (3037467)
Ketones [Presence] in Urine by Test strip
2514-8 (3035350)
Nitrite [Presence] in Urine by Test strip
5802-4 (3021601)
Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 (3041942)
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 (3014218)
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 (40763086)
Glucose [Presence] in Urine by Test strip
25428-4 (3009261)
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 (3016771)
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 (3000067)
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 (3020059)
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 (3019800)
Bicarbonate [Moles/volume] in Capillary blood
1961-2 (3015235)
Multiple cystostatic therapy of methastized malignancy
WD115 (2001310679)
Albumin [Presence] in Urine by Test strip
50949-7 (3029937)
Oncology Clinic/Center
261QX0200X (38004268)
Cells panel - Urine sediment
58434-2 (40761535)
Immunofixation for Serum or Plasma
25700-6 (3037756)
lenalidomide; oral
L04AX04 (21603930)
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 (3029338)
Measurement of bone density from two or more locations with X-ray
NK6QA (2001308500)
erdosteine; oral
R05CB15 (21603394)
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 (3001334)
Complement+Immunoglobulin [Units/volume] in Red Blood Cells
4533-6 (3024403)
Reticulocyte production index
31111-8 (3000012)
Vancomycin [Mass/volume] in Serum or Plasma
20578-1 (3005715)
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 (3034780)
Other specified special examinations
Z01.8 (45581003)
sulfadiazine and trimethoprim
J01EE02 (21602962)
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 (3005895)
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 (3015399)
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 (3017766)
Immunization
WW200 (2001310599)
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 (3000620)
magnesium hydroxide; oral
A02AA04 (21600052)
magnesium hydroxide; oral
G04BX01 (21602658)
Spirometry for bronchospasm with prolonged evaluation after bronchodilator
113016006 (4010399)
potassium chloride; oral
A12BA01 (21600877)
ciprofloxacin; oral, parenteral
J01MA02 (21603009)
pH of Urine
2756-5 (3015736)
Cancer Ag 15-3 [Units/volume] in Serum or Plasma
6875-9 (3006588)
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 (3016407)
insulin (human); parenteral
A10AD01 (21600729)
Protein electrophoresis panel - 24 hour Urine
81231-3 (21494890)
insulins and analogues for injection, intermediate-acting - combinations; parenteral
A10AC30 (21600727)
Lymph node Pathology biopsy report
66112-4 (40768795)
Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
14277-8 (3004383)
Atherosclerotic heart disease
I25.1 (45596196)
Infiltration anesthesia
WX110 (2001310767)
pantoprazole; oral, parenteral
A02BC02 (21600097)
palonosetron, combinations
A04AA55 (45893275)
General Practice
1 (38004446)
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
88518-6 (36304997)
Thorax CT examination
GD1AD (2001303618)
Subcutaneous
ZX112 (2001311492)
Multidisciplinary treatment meeting
WZC20 (2001310890)
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 (3012336)
Cardiology
6 (38004451)
Hemoglobin [Presence] in Urine by Test strip
5794-3 (3011397)
Extractable nuclear Ab [Units/volume] in Serum
30342-0 (3015171)
Gastroenterology
10 (38004455)
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 (3007220)
Extensive structural and functional ultrasound examination of heart
FM1EE (2001303307)

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
208
98
29.76
290.34
2.5
1.4
—
—
—
0
0
208
98
29.76
290.34
2.5
1.4
—
—
—
0
0
208
98
29.76
290.34
2.5
1.4
—
—
—
0
0
208
98
29.76
290.34
2.5
1.4
—
—
—
0
0
173
57
39.97
272.23
3.0
1.9
1039.75
1230.14
e6/l
0.46
167
50
147
41
45.10
241.52
3.8
2.4
35.79
42.86
%
1.52
94
25
346
554
11.36
231.41
7.3
2.8
8.31
10.93
g/l
10.40
341
513
396
850
9.41
201.92
2.4
1.5
—
—
—
0
0
251
332
11.22
191.74
3.1
2.0
0.95
2.21
ug/l
0.76
239
300
588
2041
12.67
185.74
12.5
4.6
—
—
—
0
0
417
1046
8.37
179.70
2.6
2.1
—
—
—
0
0
96
19
58.39
169.30
2.1
1.7
34.27
33.26
%
0.08
96
19
144
110
16.22
156.61
3.1
2.7
—
—
—
0
0
106
44
28.20
152.27
3.5
2.0
218.96
208.16
e6/l
0.10
101
38
353
865
7.21
151.27
2.1
1.8
—
—
—
0
0
148
126
14.62
150.94
2.6
2.5
—
—
—
0
0
252
444
8.30
148.53
3.4
1.7
1.02
1.43
g/l
2.14
224
412
290
644
6.97
135.47
11.2
4.8
1.12
0.90
%
0.85
225
211
359
978
6.47
134.98
15.0
6.0
1.07
1.03
mmol/l
1.36
353
909
196
295
8.83
131.56
2.9
1.5
8.60
12.07
iu/ml
—
14
8
94
42
25.69
130.95
3.4
1.9
512.01
642.62
e6/l
0.25
84
34
231
427
7.58
128.66
1.8
1.5
—
—
—
0
0
137
133
12.56
127.88
2.3
1.6
—
—
—
0
0
390
1204
6.05
125.79
8.4
3.5
0.80
0.82
mmol/l
1.44
380
1131
635
3103
12.11
119.93
24.6
6.6
8.90
9.09
%
0.66
627
2913
636
3147
12.01
117.39
24.6
6.5
24.15
26.71
%
4.51
629
2987
537
2285
6.77
116.55
22.3
6.2
—
—
—
0
0
628
3106
10.81
114.66
24.2
6.5
2.09
2.89
%
19.61
620
2917
128
137
11.21
111.25
1.6
1.4
—
—
—
0
0
622
3102
9.92
110.70
24.6
6.5
0.57
0.67
%
4.57
616
2908
122
124
11.70
109.88
1.6
1.4
124.03
151.75
au/ml
1.08
39
39
644
3348
12.36
108.89
22.3
6.3
0.64
0.60
e9/l
2.09
611
2856
645
3362
12.50
108.64
22.3
6.4
0.04
0.04
e9/l
5.23
613
2875
70
23
33.70
108.01
1.2
1.5
—
—
—
0
0
646
3402
12.46
106.66
22.7
6.4
2.06
1.90
e9/l
0.29
623
2986
264
660
5.81
105.53
2.3
1.6
—
—
—
0
0
647
3455
12.33
103.88
24.7
6.5
0.15
0.20
e9/l
16.09
624
3005
279
763
5.41
99.89
2.0
1.6
—
—
—
0
0
307
916
5.18
98.83
12.6
8.4
10.63
11.93
kpa
5.30
295
888
307
916
5.18
98.83
12.6
8.4
4.78
5.12
kpa
8.26
296
884
247
614
5.67
98.64
11.5
4.7
0.66
0.61
%
0.21
182
195
299
889
5.12
96.30
6.2
2.7
2.00
1.82
%
1.61
288
809
303
911
5.10
96.25
12.6
8.5
7.44
7.42
ph
6.65
191
524
243
609
5.58
95.86
12.1
4.9
0.16
0.14
%
0.20
178
177
300
902
5.07
95.12
12.3
8.5
1.23
1.00
mmol/l
0.48
252
749
100
95
12.11
93.85
1.7
1.3
—
—
—
0
0
178
347
6.54
91.85
2.5
2.0
1.56
1.48
g/l
0.37
150
308
118
148
9.38
90.50
6.6
4.0
—
—
—
0
0
653
3744
11.87
90.24
42.4
10.1
4.30
4.15
e9/l
0.85
628
3264
256
702
5.17
90.23
5.9
2.8
71.78
70.78
e9/l
0.14
194
532
638
3586
9.67
89.80
22.8
7.1
10.10
11.67
umol/l
4.35
632
3435
585
3066
6.49
88.61
15.5
5.4
32.68
35.30
g/l
19.80
570
2887
475
2120
4.85
88.27
14.1
4.3
7.40
7.40
ph
1.89
406
1535
128
183
8.33
88.08
1.4
1.3
—
—
—
0
0
84
67
14.11
87.80
1.6
1.1
—
—
—
0
0
110
131
9.77
87.74
1.4
1.3
264.12
267.75
u/ml
0.03
77
72
232
620
5.10
83.66
12.4
5.1
0.61
0.17
%
0.58
165
163
257
777
4.64
78.87
9.4
3.8
7.40
7.38
ph
3.92
188
447
353
1350
4.25
78.76
4.8
3.1
514.56
538.06
mosm/kgh2o
1.50
344
1184
613
3518
6.91
78.29
26.5
7.8
1.20
1.21
mmol/l
3.50
540
3040
247
742
4.60
76.10
9.4
3.8
1.88
1.94
mmol/l
0.08
221
638
229
649
4.76
76.02
3.2
2.2
371.58
382.06
nmol/l
0.21
224
608
313
1125
4.22
75.58
4.3
2.6
2.10
2.27
g/l
5.70
300
1044
577
3206
5.52
75.13
21.9
6.9
1.20
1.21
mmol/l
4.25
566
2947
324
1204
4.14
74.43
4.3
2.7
11.51
12.72
umol/l
2.65
315
1122
258
830
4.34
72.07
12.9
8.7
94.48
95.37
%
1.18
250
807
295
1056
4.10
70.85
4.4
2.6
22.28
22.59
%
0.15
288
990
217
623
4.60
70.29
1.8
1.4
—
—
—
0
0
90
115
8.83
67.46
8.9
4.0
1.41
1.33
%
0.06
85
105
131
256
6.06
66.28
1.6
1.3
—
—
—
0
0
254
869
4.02
64.11
1.7
1.3
320.59
483.02
titre
1.61
68
212
239
784
4.11
64.02
14.7
9.0
113.42
121.16
g/l
5.88
234
768
69
66
11.49
63.96
1.6
1.4
0.43
0.47
g/l
0.21
42
49
69
66
11.49
63.96
1.6
1.4
6.09
8.01
g/l
1.05
43
50
69
66
11.49
63.96
1.6
1.4
1.90
2.72
g/l
2.21
46
49
68
65
11.48
63.04
1.2
1.2
—
—
—
0
0
46
21
23.37
62.76
2.7
1.5
—
—
—
0
0
337
1413
3.67
62.45
17.7
5.2
—
—
—
0
0
68
67
11.13
61.74
2.4
2.4
24.09
60.70
iu/ml
—
11
7
105
179
6.72
60.78
2.5
1.7
—
—
—
0
0
362
1613
3.57
60.53
4.9
2.7
3.91
4.95
e6/l
1.01
354
1475
563
3332
4.50
60.52
18.5
15.3
1.21
1.27
inr
1.81
506
2755
67
68
10.79
59.57
1.6
1.4
—
—
—
0
0
185
529
4.39
59.31
6.7
2.7
—
—
—
0
0
386
1818
3.50
58.52
9.3
2.9
348.81
352.21
umol/l
0.25
368
1581
84
117
8.02
58.41
1.5
1.8
0.49
0.85
g/l
0.93
53
93
41
17
25.55
57.95
1.5
1.2
—
—
—
0
0
445
2305
3.55
57.49
6.6
3.5
52.69
84.49
e6/l
0.36
394
1792
402
2007
3.35
54.13
6.5
3.4
0.26
0.50
e6/l
2.89
348
1493
301
1270
3.40
53.51
3.2
1.5
2.30
2.62
g/l
1.14
240
752
609
3998
4.99
52.26
15.6
5.5
6.90
6.78
mmol/l
0.59
600
3820
64
73
9.55
52.16
1.5
1.2
—
—
—
0
0
463
2563
3.38
51.48
8.1
4.2
52.82
94.99
e6/l
1.08
399
1853
116
255
5.25
51.03
9.6
3.9
64.92
73.98
mg/l
0.14
94
217
199
664
3.79
50.68
15.7
8.9
—
—
—
0
0
115
254
5.22
50.29
9.6
3.9
58.69
60.51
mg/l
0.04
94
219
494
2891
3.40
49.02
41.3
12.2
0.01
0.00
e9/l
0.58
439
2375
431
2370
3.13
46.82
10.3
3.8
2.32
2.35
mmol/l
5.02
414
2134
163
499
3.95
46.71
6.3
3.7
7.43
7.42
ph
1.15
150
417
422
2298
3.10
46.56
4.9
3.2
2198.08
1297.61
ng/l
2.62
395
1980
315
1459
3.10
46.42
2.5
1.7
1.90
1.46
mg/l
0.61
279
1146
163
507
3.89
45.58
12.6
7.7
24.34
24.54
mmol/l
0.26
156
487
399
2125
3.04
45.48
4.0
2.8
63.48
61.79
u/l
0.11
383
1970
104
234
5.04
44.30
9.0
3.6
4.15
2.66
ratio
0.30
61
136
81
146
6.14
43.99
7.0
3.1
57.49
58.46
%
0.19
81
146
60
79
8.21
43.52
1.4
1.2
—
—
—
0
0
55
71
8.32
40.51
1.3
1.1
—
—
—
0
0
207
804
3.23
40.50
2.2
1.7
—
—
—
0
0
88
185
5.30
40.43
4.1
2.3
119.23
128.76
g/l
2.52
70
144
73
130
6.15
40.05
8.9
4.8
2.63
2.40
mmol/l
0.28
60
91
603
4262
3.97
38.79
8.5
4.8
1578.10
1204.69
e6/l
—
10
65
343
1797
2.78
38.42
3.0
2.3
3.20
2.94
mg/l
1.23
325
1529
113
305
4.22
38.10
1.6
1.3
—
—
—
0
0
373
2047
2.76
38.01
4.4
3.3
—
—
—
0
0
105
273
4.35
37.17
2.3
1.8
8.33
8.11
iu/ml
0.03
25
65
65
112
6.29
36.81
6.1
6.2
12.01
11.62
mg/l
0.25
60
104
361
2012
2.64
34.72
25.4
6.3
—
—
—
0
0
87
210
4.59
33.76
2.0
1.4
0.24
0.23
g/l
0.41
82
200
512
3426
2.83
33.32
7.1
4.0
0.00
0.00
estimate
-0.00
165
720
177
704
3.03
32.48
2.7
2.4
0.22
0.21
g/l
1.27
162
657
154
567
3.20
32.28
4.5
3.2
182.12
198.22
ng/l
0.22
144
524
189
782
2.94
32.28
6.7
3.0
7.17
8.61
umol/l
0.55
170
704
513
3469
2.79
32.08
7.2
4.1
16.02
2.56
estimate
0.61
167
735
515
3491
2.79
32.02
7.2
4.1
0.00
0.46
estimate
0.52
156
677
601
4436
3.49
31.76
9.9
4.7
—
2.23
—
0
7
124
404
3.51
31.63
2.1
1.2
222.92
283.31
u/ml
0.25
108
373
374
2193
2.51
31.30
8.0
3.4
36.14
33.73
u/l
0.32
366
2062
191
816
2.84
30.55
5.5
3.2
4.82
4.72
e9/l
0.09
184
704
60
115
5.61
30.36
1.1
1.1
—
—
—
0
0
431
2748
2.48
29.31
5.8
3.7
6.31
6.21
ph
1.03
241
1518
30
27
11.56
28.62
1.2
1.2
—
—
—
0
0
56
109
5.50
27.84
1.1
1.1
—
—
—
0
0
307
1713
2.41
27.75
10.4
4.3
88.47
87.87
%
0.16
297
1692
143
548
3.02
27.66
6.8
4.2
110.85
85.83
ng/l
2.10
130
489
460
3078
2.44
27.22
6.9
3.0
—
—
estimate
—
0
0
260
1356
2.46
27.22
6.5
4.2
180.84
327.48
ng/l
1.07
238
1130
436
2870
2.37
26.47
5.3
3.0
339.89
147.93
ug/l
3.41
421
2640
43
69
6.57
26.00
4.7
2.4
—
—
—
0
0
61
137
4.78
25.73
1.4
1.3
67.63
59.33
mmol/l
0.77
56
118
360
2203
2.30
25.70
6.4
2.6
—
—
—
0
0
72
190
4.11
24.72
4.2
3.2
3.34
1.70
index
1.17
38
109
242
1272
2.38
24.41
5.2
3.1
1.00
0.93
e6/l
0.10
154
705
62
148
4.50
24.25
1.5
1.2
—
—
—
0
0
35
49
7.47
23.93
2.7
2.0
—
—
—
0
0
225
1158
2.39
23.70
5.7
3.3
1.41
1.83
e6/l
0.60
139
590
128
523
2.77
21.67
7.1
3.8
—
—
—
0
0
29
11
27.42
21.49
1.2
1.7
—
—
—
0
0
97
344
3.11
21.19
1.8
1.7
—
—
—
0
0
110
423
2.90
20.82
7.2
2.7
1.19
1.18
%
0.02
110
423
48
107
4.74
20.39
4.9
2.2
32.77
32.76
pg
0.01
48
107
332
2113
2.09
19.85
2.1
1.7
17.75
20.34
nmol/l
2.82
303
1763
250
1432
2.16
19.71
5.1
3.2
2.47
2.46
mmol/l
0.82
234
1285
419
2917
2.08
19.50
3.9
2.5
76.92
78.36
nmol/l
0.55
406
2580
393
2676
2.07
19.39
6.6
4.1
32.63
75.36
ng/l
1.16
348
2059
37
70
5.52
18.91
1.2
1.2
—
—
—
0
0
53
136
4.13
18.84
1.2
1.2
—
—
—
0
0
140
638
2.49
18.83
3.9
2.6
38.89
35.64
u/l
0.37
126
534
30
49
6.35
17.78
1.6
1.2
3.34
0.23
u/ml
0.61
17
27
24
31
7.98
17.51
1.4
1.5
61.47
64.87
mg/l
0.06
19
24
33
61
5.63
17.28
1.2
1.2
—
—
—
0
0
48
122
4.15
17.27
1.8
1.2
—
—
—
0
0
76
267
3.07
16.78
5.5
3.8
1.53
1.35
mmol/l
0.68
71
261
197
1091
2.12
16.47
1.3
1.3
39.45
12.81
u/ml
1.70
54
413
279
1763
1.97
16.12
5.5
3.2
0.13
0.05
—
8
39
23
11
21.56
16.06
1.0
1.1
—
—
—
0
0
51
146
3.69
15.56
1.8
1.2
113.60
10.40
e6/l
0.45
40
108
67
230
3.12
15.37
13.3
8.8
1.33
1.30
mmol/l
0.11
61
204
29
53
5.66
15.36
1.5
1.2
90.00
104.00
titre
—
6
10
283
1823
1.93
15.24
6.8
3.5
0.04
0.05
estimate
0.09
141
569
23
13
18.25
15.23
4.9
2.5
2.87
2.54
%
0.08
23
13
321
2163
1.89
15.00
3.7
2.2
103.24
245.94
u/l
3.57
310
2057
23
34
6.96
14.94
1.9
1.5
—
—
—
0
0
35
78
4.67
14.86
3.9
2.8
1.11
1.26
g/24h
0.09
25
46
366
2584
1.87
14.67
7.3
4.1
0.01
0.01
estimate
0.09
149
598
359
2521
1.87
14.61
2.6
2.2
—
—
—
0
0
200
1167
2.00
14.22
1.3
1.3
68.16
33.93
iu/ml
1.97
81
354
150
787
2.15
14.20
5.5
4.4
16.78
30.60
ug/l
0.40
123
664
34
77
4.59
14.16
1.1
1.1
—
—
—
0
0
34
78
4.53
13.94
1.6
1.1
—
—
—
0
0
28
55
5.26
13.73
2.6
2.9
15.13
16.71
%
1.54
28
55
34
79
4.47
13.72
1.6
1.1
—
—
—
0
0
199
1178
1.96
13.47
1.8
1.7
1205.02
1203.95
nmol/l
0.00
168
890
44
126
3.66
13.41
1.3
1.3
213.72
181.09
miu/ml
—
5
49
46
137
3.52
13.23
6.1
3.0
13.77
8.91
pmol/l
1.24
46
137
21
16
13.49
12.49
1.0
1.0
—
—
—
0
0
22
19
11.91
12.38
2.0
2.0
—
—
—
0
0
288
1961
1.80
12.34
7.2
4.2
0.00
0.01
estimate
0.78
140
664
51
170
3.16
12.28
2.5
3.2
30.91
34.40
umol/l
0.63
45
151
23
42
5.63
12.18
1.0
1.0
—
—
—
0
0
262
1749
1.80
11.90
1.7
1.4
—
—
—
0
0
21
36
5.98
11.85
1.0
1.1
—
—
—
0
0
20
16
12.83
11.68
1.2
1.1
—
—
—
0
0
16
7
23.35
11.61
1.9
1.0
—
—
—
0
0
16
7
23.35
11.61
1.9
1.0
—
—
—
0
0
16
7
23.35
11.61
1.9
1.0
—
—
—
0
0
50
174
3.02
11.20
1.4
1.2
—
—
—
0
0
79
349
2.42
11.13
7.0
3.8
—
—
—
0
0
669
6053
3.31
10.98
77.4
17.9
27.92
25.78
mg/l
1.54
663
5058
33
89
3.84
10.97
1.4
1.2
6.21
7.29
u/ml
0.12
14
41
21
39
5.52
10.93
1.3
1.2
5.62
6.76
u/l
0.35
16
32
21
22
9.80
10.81
3.4
2.0
0.60
0.59
mmol/l
0.19
21
22
22
26
8.70
10.60
1.1
1.1
—
—
—
0
0
22
26
8.70
10.60
1.1
1.1
—
—
—
0
0
22
26
8.70
10.60
1.1
1.1
—
—
—
0
0
26
60
4.46
10.59
1.4
1.2
—
—
—
0
0
19
18
10.81
10.32
4.5
4.9
—
—
—
0
0
116
619
2.05
10.29
2.3
2.5
7.67
6.68
ug/l
0.24
103
556
401
3104
1.68
10.13
2.5
2.2
91.50
95.34
pmol/l
1.00
267
1601
15
9
17.00
9.90
1.2
1.0
—
—
—
0
0
15
9
17.00
9.90
1.5
1.2
—
—
—
0
0
26
64
4.18
9.77
2.5
2.3
—
—
—
0
0
33
97
3.52
9.71
1.6
1.3
2536.23
1581.19
e6/l
0.59
26
63
22
31
7.29
9.56
2.2
2.1
62.27
65.73
ug/l
0.06
22
31
30
84
3.69
9.47
1.6
1.3
—
—
—
0
0
20
41
4.99
9.36
4.8
3.4
0.75
0.85
index
0.34
20
41
49
187
2.74
9.30
1.7
1.2
7.40
2.59
u/ml
—
6
21
111
609
1.98
9.06
3.7
2.5
0.40
0.45
e6/l
0.12
111
586
24
60
4.11
8.85
1.5
1.1
—
—
—
0
0
16
15
10.89
8.82
1.4
1.5
—
—
—
0
0
27
74
3.75
8.80
1.6
1.4
19.14
29.61
ng/l
1.19
27
74
12
6
20.31
8.49
2.7
3.5
—
—
—
0
0
18
24
7.67
8.20
2.5
2.2
—
—
—
0
0
16
19
8.59
7.84
1.3
1.1
0.47
4.37
mmol/l
0.52
11
11
12
8
15.23
7.73
1.2
1.0
—
—
—
0
0
12
8
15.23
7.73
1.2
1.0
—
—
—
0
0
17
23
7.55
7.71
3.4
1.6
2.10
1.84
umol/l
0.44
17
17
62
291
2.24
7.60
1.6
1.3
—
—
—
0
0
13
11
12.01
7.60
1.8
1.3
—
—
—
0
0
21
54
3.98
7.48
1.1
1.1
128.00
101.57
pmol/l
0.64
21
54
481
4054
1.59
7.40
5.8
3.5
82.02
54.54
u/l
4.41
464
3770
63
305
2.17
7.17
4.1
3.9
461.30
4841.53
u/ml
0.74
57
264
55
254
2.26
7.02
5.9
3.9
297.66
230.79
mg/l
0.24
47
113
26
83
3.21
6.77
1.7
1.3
60712.53
42921.40
e6/l
0.13
17
43
26
83
3.21
6.77
1.5
1.2
—
116.66
—
0
5
104
614
1.81
6.73
2.7
1.5
—
—
—
0
0
20
54
3.78
6.68
2.2
2.8
9.14
8.07
mmol/l
0.35
20
54
21
61
3.52
6.33
1.9
1.3
42.13
30.68
%
0.60
15
41
13
17
7.77
6.14
4.0
2.6
—
—
—
0
0
35
140
2.58
6.12
1.8
1.5
—
—
—
0
0
140
925
1.64
6.02
1.4
1.3
—
—
—
0
0
123
788
1.68
5.95
1.4
1.3
—
—
—
0
0
25
85
3.01
5.89
4.9
2.9
4.23
4.05
mmol/l
0.82
25
85
45
210
2.22
5.63
1.3
1.4
242.11
276.56
ug/g
0.54
28
127
24
84
2.92
5.40
5.0
3.0
1.18
1.19
mmol/l
0.47
24
84
14
25
5.69
5.39
1.4
1.4
2.14
3.82
mmol/l
1.61
14
20
24
85
2.89
5.29
5.0
2.9
106.17
105.20
mmol/l
0.42
24
85
99
633
1.66
4.80
2.9
2.1
0.12
0.02
estimate
0.35
26
121
193
1437
1.47
4.77
1.6
1.8
124706341.68
26113450.15
pmol/l
0.57
170
1168
35
161
2.24
4.57
1.8
1.4
12.56
8.05
u/l
0.74
24
122
9
11
8.27
4.57
7.0
3.0
17.40
26.18
mg/mmol
—
9
11
666
6314
2.10
4.55
75.2
21.7
138.44
139.68
mmol/l
26.68
666
6200
21
77
2.78
4.38
1.3
1.2
—
—
—
0
0
7
6
11.77
4.28
1.3
1.2
—
—
—
0
0
111
756
1.56
4.15
3.6
2.5
236.15
127.25
ug/g
1.39
95
598
23
92
2.55
4.08
4.9
2.0
5562.65
5850.12
u/l
0.01
11
30
201
1548
1.42
4.06
7.0
4.3
1.02
1.02
kg/l
0.33
166
1054
58
335
1.80
4.06
2.6
3.6
3.91
4.50
pmol/l
3.94
51
289
7
7
10.08
4.01
1.3
1.1
—
—
u/ml
—
0
0
39
198
2.03
4.00
1.5
1.2
117.14
82.67
titre
—
7
15
10
18
5.62
3.98
1.1
1.4
26.00
26.78
s
—
10
18
32
151
2.17
3.96
2.6
3.2
0.85
0.88
nmol/l
0.09
24
121
15
48
3.17
3.95
1.4
1.1
—
—
—
0
0
59
347
1.76
3.89
2.2
2.4
—
—
—
0
0
8
11
7.34
3.86
1.1
1.1
—
—
—
0
0
20
77
2.64
3.83
16.7
2.0
8.04
10.56
%
2.14
20
77
20
78
2.61
3.74
2.3
1.5
51.38
62.04
%
0.50
13
50
13
34
3.88
3.70
2.2
1.5
44.68
61.12
%
0.86
13
26
8
12
6.73
3.68
11.9
10.3
5.76
5.40
mmol/l
—
8
12
9
16
5.68
3.66
2.7
1.9
—
—
—
0
0
15
51
2.98
3.59
1.4
1.2
—
—
—
0
0
10
21
4.81
3.56
1.2
1.1
—
23.60
u/ml
—
0
5
33
166
2.04
3.50
6.2
5.0
—
—
—
0
0
15
52
2.93
3.48
2.5
1.8
0.90
2.00
u/field
—
10
28
9
18
5.05
3.38
1.0
1.2
—
—
—
0
0
15
53
2.87
3.37
1.6
1.2
—
—
—
0
0
37
198
1.92
3.31
2.5
1.5
7607.62
13074.80
e6/l
0.73
26
139
39
214
1.87
3.25
1.4
1.2
—
555.00
—
0
6
11
29
3.84
3.19
2.4
1.5
5.09
1.07
%
0.62
11
23
518
4737
1.36
3.14
5.0
4.2
14.91
14.95
pmol/l
0.12
491
4286
650
6199
1.67
3.14
53.0
16.2
—
—
—
0
0
12
35
3.47
3.12
1.0
1.1
0.68
0.49
ratio
—
7
20
20
86
2.36
3.10
2.3
1.4
—
—
—
0
0
30
153
2.00
3.09
1.9
1.5
39.75
26.80
iu/l
0.84
23
125
12
37
3.28
2.94
1.4
1.1
—
—
—
0
0
120
893
1.41
2.88
1.5
1.3
—
—
—
0
0
12
43
2.82
2.65
1.0
1.1
296.29
372.50
nmol/l
—
7
36
7
15
4.70
2.60
6.7
8.7
5.26
5.35
kpa
—
7
15
19
88
2.19
2.53
2.7
1.7
—
—
—
0
0
44
274
1.65
2.44
4.5
3.4
49.75
111.24
u/ml
0.66
44
265
11
38
2.92
2.42
2.4
1.2
133.00
144.06
nmol/l
0.28
11
38
6
12
5.03
2.40
1.0
1.0
—
—
—
0
0
16
71
2.28
2.36
1.6
1.2
7379.91
288349.98
e6/l
1.34
11
51
9
28
3.24
2.31
1.2
1.1
—
—
—
0
0
18
86
2.12
2.24
1.2
1.1
—
—
—
0
0
283
2466
1.25
2.15
5.3
3.8
—
0.70
—
0
10
26
146
1.81
2.09
1.3
1.4
—
—
—
0
0
5
10
5.03
2.07
1.0
1.0
16.68
16.26
g/l
—
5
10
7
175
0.39
2.06
2.0
1.6
—
—
—
0
0
26
148
1.79
2.01
1.3
1.6
221.00
302.53
mu/l
1.28
21
136
26
150
1.76
1.93
1.3
1.9
115.44
4.35
iu/l
—
8
52
672
6543
1.65
1.93
97.7
27.2
93.00
91.49
fl
11.73
672
6470
27
158
1.74
1.91
5.1
3.7
419.48
1934.43
u/ml
0.47
27
148
672
6545
1.65
1.90
100.7
27.8
36.92
40.38
%
56.32
672
6469
672
6545
1.65
1.90
97.6
27.2
30.64
30.44
pg
1.88
672
6472
49
335
1.50
1.88
2.9
2.2
0.00
0.01
estimate
0.50
18
99
10
40
2.52
1.67
1.2
1.3
—
—
—
0
0
595
6164
0.77
1.65
6.3
6.3
2.52
2.62
mmol/l
2.13
549
5663
10
41
2.46
1.65
1.1
1.1
—
7.49
—
0
10
40
271
1.50
1.62
1.1
1.1
—
35.17
—
0
6
16
84
1.93
1.60
1.4
1.2
—
—
—
0
0
136
1617
0.80
1.51
2.3
3.4
0.67
0.75
ug/l
0.54
90
1104
13
65
2.02
1.49
1.5
1.2
—
—
—
0
0
276
2475
1.19
1.45
6.1
4.3
14.35
8.96
mg/mmol
1.30
208
1558
50
366
1.39
1.39
1.2
1.2
35.50
146.71
u/ml
5.72
15
137
5
122
0.41
1.38
1.0
1.6
—
—
—
0
0
278
2504
1.18
1.37
5.7
3.5
6.61
7.72
mmol/l
4.30
256
2105
56
423
1.35
1.30
1.5
1.4
—
—
—
0
0
66
513
1.32
1.27
3.4
2.4
6.15
6.07
ph
0.32
57
349
268
2429
1.17
1.20
5.7
3.5
74.13
47.97
mg/l
1.15
207
1586
8
38
2.12
1.18
1.3
1.2
4.01
6.01
ug/l
—
8
32
164
1430
1.19
1.16
1.3
1.3
0.71
1.27
u/ml
1.80
41
374
13
72
1.82
1.15
1.2
1.2
1.38
1.78
nmol/l
0.47
13
64
42
310
1.38
1.15
2.1
2.9
—
—
—
0
0
11
59
1.88
1.08
1.7
1.8
—
—
—
0
0
589
6060
0.82
1.07
5.8
5.5
4.42
4.51
mmol/l
1.36
549
5589
20
130
1.55
1.03
6.5
3.9
35.47
26.14
mg/l
0.44
15
88
13
75
1.75
1.03
3.1
3.0
3.27
5.66
nmol/l
0.56
13
75
7
34
2.07
1.03
1.3
1.4
—
—
—
0
0
10
53
1.90
1.01
1.0
1.2
—
2.23
—
0
6
197
2182
0.86
0.97
3.9
3.5
—
—
—
0
0
587
6026
0.84
0.92
5.6
5.4
1.37
1.44
mmol/l
3.73
545
5520
13
78
1.68
0.92
1.1
1.3
0.17
0.19
nmol/l
—
6
58
26
192
1.37
0.76
1.0
1.1
—
—
—
0
0
5
24
2.09
0.74
2.8
2.0
—
—
—
0
0
9
56
1.61
0.72
1.0
1.0
—
—
—
0
0
12
182
0.65
0.71
1.0
1.2
—
—
—
0
0
9
144
0.62
0.70
1.1
1.2
1.64
1.51
g/l
—
9
144
5
28
1.79
0.66
3.0
2.0
—
—
—
0
0
588
6004
0.87
0.65
6.3
5.6
6.09
6.04
mmol/l
0.31
549
5457
20
266
0.74
0.60
1.1
1.1
—
—
—
0
0
6
36
1.67
0.56
1.7
1.6
121.42
154.69
pmol/l
—
6
36
24
185
1.31
0.56
2.3
2.6
167.35
112.99
ug/min
0.36
17
101
6
37
1.63
0.55
5.7
1.5
24.68
22.58
umol/l
—
6
32
34
277
1.24
0.53
1.2
1.5
0.53
0.34
mg/l
0.57
17
129
10
66
1.52
0.52
1.1
1.2
—
—
—
0
0
58
500
1.17
0.52
1.2
1.2
—
—
—
0
0
14
191
0.73
0.51
21.4
11.2
—
—
—
0
0
9
65
1.39
0.50
9.4
1.5
—
—
—
0
0
12
167
0.71
0.49
2.1
1.9
178.75
223.59
pmol/l
0.73
12
157
16
212
0.75
0.49
1.9
1.9
46.69
40.57
nmol/l
0.36
16
203
260
2738
0.92
0.48
2.2
2.0
1.57
1.32
mmol/l
4.43
228
2252
7
46
1.53
0.48
1.0
3.3
8.56
7.21
mmol/l
—
7
26
11
76
1.45
0.48
1.2
1.3
—
—
—
0
0
11
77
1.44
0.45
1.1
1.3
—
—
nmol/l
—
0
0
7
51
1.38
0.44
3.9
1.7
—
—
—
0
0
5
33
1.52
0.41
1.4
1.1
261.80
190.29
mmol/24h
—
5
33
5
35
1.43
0.39
4.6
2.3
33.36
39.82
g/l
—
5
35
580
5884
0.92
0.35
8.0
7.1
39.98
39.88
mmol/mol
0.10
553
5468
575
5671
1.08
0.30
6.2
5.3
2.19
1.99
mu/l
0.81
540
5175
5
39
1.28
0.23
1.0
1.0
—
—
—
0
0
16
135
1.19
0.21
5.8
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
2.2
—
20.01
—
0
13
0
13
0.00
0.21
0.0
1.1
—
39.69
—
0
13
0
14
0.00
0.20
0.0
2.2
—
2.97
—
0
6
16
136
1.18
0.20
5.8
1.4
—
—
—
0
0
16
136
1.18
0.20
5.8
1.4
—
—
—
0
0
16
136
1.18
0.20
5.8
1.4
—
—
—
0
0
6
51
1.18
0.19
1.2
1.4
0.89
1.28
promille
—
6
42
571
5764
0.95
0.19
5.2
4.6
1.44
1.30
mmol/l
4.42
528
5236
281
2743
1.04
0.19
4.9
5.9
3.70
2.54
ug/l
0.65
255
2453
66
619
1.07
0.18
2.7
2.5
11.23
13.21
nmol/l
0.97
58
557
14
156
0.90
0.10
2.6
1.2
0.98
0.89
g/l
0.58
14
156
5
44
1.14
0.10
1.8
1.4
97.00
77.95
umol/l
—
5
44
14
130
1.08
0.04
6.5
1.4
—
—
—
0
0
43
423
1.02
0.01
1.2
1.2
—
—
—
0
0
31
312
0.99
0.00
2.6
1.9
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.2
—
0.43
—
0
6
6
60
1.00
-0.00
2.3
2.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
31.67
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_PNEUMOCYSTOSIS and mortality.

Females

Parameter HR [95% CI] p-value
AB1_PNEUMOCYSTOSIS 10.609 [7.15, 15.75] < 0.001
Birth year 1.003 [0.99, 1.01] 0.449

During the follow-up period (1.1.1998 — 31.12.2019), 296 out of 647 females with AB1_PNEUMOCYSTOSIS died.

Males

Parameter HR [95% CI] p-value
AB1_PNEUMOCYSTOSIS 5.697 [4.03, 8.05] < 0.001
Birth year 0.985 [0.98, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 404 out of 853 males with AB1_PNEUMOCYSTOSIS died.

Mortality risk

Mortality risk for people of age

years, who have AB1_PNEUMOCYSTOSIS.

N-year risk Females Males
1 1.668% 1.058%
5 7.866% 6.012%
10 18.753% 14.416%
15 32.72% 25.087%
20 51.67% 40.573%

Relationships between endpoints

↥

Index endpoint: AB1_PNEUMOCYSTOSIS – Pneumocystosis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data